Robert Olstein recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Robert A. Olstein is the Chairman and Chief Investment Officer of the Olstein Financial Alert Fund (OFALX). He is considered to be an expert in corporate financial disclosure and reporting practices. In 1971, he co-founded the "Quality of Earnings Report" service, which pioneered the concept of using inferential financial screening techniques to analyze balance sheets and income statements to alert institutional portfolio managers to positive or negative factors affecting a company's future earnings power and value of a company's stock.
As of the latest 13F report, the guru’s equity portfolio contained 98 stocks valued at a total of $637.00Mil. The top holdings were GNRC(1.90%), CSCO(1.86%), and ST(1.81%).
According to GuruFocus data, these were Robert Olstein (Trades, Portfolio)’s top five trades of the quarter.
Generac Holdings Inc
During the quarter, Robert Olstein (Trades, Portfolio) bought 65,250 shares of NYSE:GNRC for a total holding of 120,000. The trade had a 1.03% impact on the equity portfolio. During the quarter, the stock traded for an average price of $113.16.
On 02/06/2023, Generac Holdings Inc traded for a price of $121.48 per share and a market cap of $7.70Bil. The stock has returned -56.61% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Generac Holdings Inc has a price-earnings ratio of 18.27, a price-book ratio of 3.32, a price-earnings-to-growth (PEG) ratio of 0.73, a EV-to-Ebitda ratio of 11.83 and a price-sales ratio of 1.71.
The price-to-GF Value ratio is 0.33, earning the stock a GF Value rank of 2.
Zimmer Biomet Holdings Inc
Robert Olstein (Trades, Portfolio) reduced their investment in NYSE:ZBH by 31,500 shares. The trade had a 0.55% impact on the equity portfolio. During the quarter, the stock traded for an average price of $116.05.
On 02/06/2023, Zimmer Biomet Holdings Inc traded for a price of $127.835 per share and a market cap of $26.83Bil. The stock has returned 8.27% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Zimmer Biomet Holdings Inc has a price-earnings ratio of 96.84, a price-book ratio of 2.19, a EV-to-Ebitda ratio of 21.01 and a price-sales ratio of 3.41.
The price-to-GF Value ratio is 1.06, earning the stock a GF Value rank of 5.
Universal Health Services Inc
Robert Olstein (Trades, Portfolio) reduced their investment in NYSE:UHS by 35,000 shares. The trade had a 0.52% impact on the equity portfolio. During the quarter, the stock traded for an average price of $118.04.
On 02/06/2023, Universal Health Services Inc traded for a price of $145.42 per share and a market cap of $10.38Bil. The stock has returned 12.64% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Universal Health Services Inc has a price-earnings ratio of 14.96, a price-book ratio of 1.77, a price-earnings-to-growth (PEG) ratio of 2.37, a EV-to-Ebitda ratio of 9.70 and a price-sales ratio of 0.84.
The price-to-GF Value ratio is 0.87, earning the stock a GF Value rank of 7.
Fidelity National Information Services Inc
During the quarter, Robert Olstein (Trades, Portfolio) bought 43,997 shares of NYSE:FIS for a total holding of 144,497. The trade had a 0.47% impact on the equity portfolio. During the quarter, the stock traded for an average price of $71.04000000000001.
On 02/06/2023, Fidelity National Information Services Inc traded for a price of $73.5 per share and a market cap of $43.61Bil. The stock has returned -33.55% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Fidelity National Information Services Inc has a price-earnings ratio of 48.04, a price-book ratio of 0.97, a EV-to-Ebitda ratio of 11.31 and a price-sales ratio of 3.08.
The price-to-GF Value ratio is 0.52, earning the stock a GF Value rank of 4.
International Flavors & Fragrances Inc
The guru established a new position worth 28,000 shares in NYSE:IFF, giving the stock a 0.46% weight in the equity portfolio. Shares traded for an average price of $98.31 during the quarter.
On 02/06/2023, International Flavors & Fragrances Inc traded for a price of $112.41 per share and a market cap of $28.66Bil. The stock has returned -9.21% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, International Flavors & Fragrances Inc has a price-book ratio of 1.70, a EV-to-Ebitda ratio of -4423.16 and a price-sales ratio of 2.28.
The price-to-GF Value ratio is 0.83, earning the stock a GF Value rank of 9.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
